{
    "Trade/Device Name(s)": [
        "IMDx HSV-1/2 for Abbott m2000"
    ],
    "Submitter Information": "Intelligent Medical Devices, Inc.",
    "510(k) Number": "K140198",
    "Predicate Device Reference 510(k) Number(s)": [
        "K100336"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OQO"
    ],
    "Summary Letter Date": "April 15, 2014",
    "Summary Letter Received Date": "April 17, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes Simplex Virus Nucleic Acid Amplification Assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular",
        "microbiology"
    ],
    "Analyte(s)": [
        "Herpes Simplex Virus type 1 (HSV-1) DNA",
        "Herpes Simplex Virus type 2 (HSV-2) DNA"
    ],
    "Specimen Type(s)": [
        "Skin lesion (anogenital or oral)"
    ],
    "Specimen Container(s)": [
        "M4RT viral transport medium"
    ],
    "Instrument(s)/Platform(s)": [
        "Abbott m2000 instrument system"
    ],
    "Method(s)/Technology(ies)": [
        "Polymerase Chain Reaction (PCR)",
        "Real-time PCR",
        "Fluorescent hydrolysis probe detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Qualitative molecular detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Reagent",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for IMDx HSV-1/2 qualitative molecular assay for HSV-1 and HSV-2 DNA detection using PCR on Abbott m2000 platform",
    "Indications for Use Summary": "In vitro diagnostic test for qualitative detection and differentiation of HSV-1 and HSV-2 DNA from male and female skin lesions (anogenital or oral) in symptomatic patients, run on Abbott m2000 instrument",
    "fda_folder": "Microbiology"
}